ZELVYSIA

Serial Number 98339539
730

Registration Progress

Application Filed
Jan 3, 2024
Under Examination
Mar 4, 2025
Approved for Publication
Sep 10, 2024
Published for Opposition
Sep 10, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Mar 04, 2026 44 days

Trademark Image

ZELVYSIA

Basic Information

Serial Number
98339539
Filing Date
January 3, 2024
Published for Opposition
September 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Aug 28, 2025
Application
Pending
Classes
005

Rights Holder

Aucta Pharmaceuticals, Inc.

03
Address
71 Suttons Lane
Piscataway, NJ 08854

Ownership History

Aucta Pharmaceuticals, Inc.

Original Applicant
03
Piscataway, NJ

Aucta Pharmaceuticals, Inc.

Owner at Publication
03
Piscataway, NJ

Legal Representation

Attorney
Christopher D. Olszyk, Jr.

USPTO Deadlines

Next Deadline
44 days remaining
NOA E-Mailed - SOU Required
Due Date
March 04, 2026
Extension Available
Until September 04, 2026

Application History

14 events
Date Code Type Description Documents
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 28, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 28, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 28, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 19, 2025 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Sep 24, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 2, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 31, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 3, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the prevention and treatment of metabolic diseases and disorders; Pharmaceutical preparations for use in the prevention and treatment of hyperphenylalaninemia and phenylketonuria; Pharmaceutical preparations for use in the treatment and reduction of elevated blood phenylalanine levels in the body

Classification

International Classes
005